Profil
Matthew E.
Colpoys is the founder of Tactiva Therapeutics LLC.
He is currently an Independent Director at NeoDynamics AB, Chief Operating Officer at Efferent Labs, Inc., and President at Galileo Consulting, Inc. Previously, he was the President & Chief Executive Officer at Woodbrook Group Holdings, Inc. from 2008 to 2009.
He received his undergraduate degree from Canisius College.
Postes actifs de Matthew E. Colpoys
| Sociétés | Poste | Début |
|---|---|---|
| NEOS AB | Directeur/Membre du Conseil | 01/01/2021 |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Directeur des opérations | - |
Galileo Consulting, Inc. | President | - |
Anciens postes connus de Matthew E. Colpoys
| Sociétés | Poste | Fin |
|---|---|---|
| WOODBROOK GROUP HOLDINGS INC. | President | 07/01/2009 |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Directeur Général | - |
Formation de Matthew E. Colpoys
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Canisius College
Canisius College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Woodbrook Group Holdings, Inc.
Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
NeoDynamics AB
NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Health Technology |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Health Technology |
Galileo Consulting, Inc. |
















